Saturday, June 30, 2018

SOLAR NOT SO SMART


             Image result for solar panel pictures
 Solar systems
Putting solar panels on the roof of one’s home, business or school is a good way to
provide an alternative to polluting conventional power plants. However, people

with electromagnetic hypersensitivity may not even be able to enter or be around
such a building. Since some of the milder symptoms of this syndrome are
common and non-specific, such as headaches and restlessness, a person using the
building may not even know his or her symptoms are caused by the solar system.
Modern solar systems use components that radiate radio frequency
electromagnetic radiation, which can cause the symptoms. The main problem is
the inverter, which is a device that takes the electricity from the solar panels and
turns it into alternating current (AC) and puts it out on the electrical grid. The
inverter generates radio frequency radiation. The wires connected to the inverter
act as antennas, so the radiation may be picked up hundreds of feet away from the
inverter. There have been cases where a solar-electric system became a problem
for an electrically sensitive person living next door.
There may be other troublesome components in a solar system as well, especially
in systems that use batteries. These systems may use the batteries to power the
building during a power outage, though in most cases they are used when the
house is in a remote rural area where there is no electrical service.
Solar EMF Hazard 2
Today’s battery systems usually use technologies that are more efficient at
charging the batteries, but which also emit radio-frequency radiation. These
technologies are called Pulse-Width-Modulation (PWM), Maximum Power Point
Tracking (MPPT) and other names.
It is easy to demonstrate that the solar system generates dirty electricity. One
method is to take a simple AM radio, set the dial at the lowest frequency and hold
the radio near the solar panels or wires. A lot of static and buzzing should be
heard, which goes away when taking the radio well away from the building.
Another method is to buy a Stetzer meter and plug it into any outlet fed by the
solar system. The instrument will probably go off the scale.
It is possible to use solar-electric systems without this radiation, but they are not
suitable for most people. One will have to do like the off-grid pioneers did in the
1970s and 1980s, using 12 volt DC electricity with no inverter, and just a simple
charge controller. There are people doing it (including this author), but it is a
significant lifestyle change. Hopefully future generations of inverter design will
be better, though it will be very difficult to fully remove this radiation.
For ultra-low EMF solar systems, see http://www.eiwellspring.org/offgrid.html










Thursday, June 28, 2018

Dr. Bergman

Friday, June 8, 2018

The Lyme vaccine and RUSSIAN ROULETTE




PETITION UPDATE

The Lyme vaccine and RUSSIAN ROULETTE

Carl Tuttle
Hudson, NH
JUN 7, 2018 — There has been a recent increase in news articles regarding Lyme disease vaccines. A number of attempts to get the editors to correct the disinformation have failed to produce full disclosure.

It is believed that a rush to create a Lyme disease vaccine led to the mishandling of the disease. Current antibody tests for Lyme disease were manipulated in 1994 at the Dearborn Conference so as to facilitate vaccine development. The two most important indicators of infection were stripped out of serology tests so that the vaccinated would test seronegative. The vast majority of truly infected patients cannot obtain a timely diagnosis leading to a missed opportunity for successful short term treatment. 

The vaccine known as LYMErix was supposed to expose the immune system to the outer surface protein A (OspA) of the spirochete responsible for causing Lyme disease but for some patients, it caused the same crippling effects of the disease itself as reported in the class action lawsuit:

https://www.dropbox.com/s/sodqs3pdeeesktf/Sheller%20Lymerix.pdf?dl=0

Excerpt from the lawsuit:

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.”

Below is the link to the Final Judgement and Approval of the class action against SmithKline Beecham as a settlement was awarded to these individuals.

JUDGEMENT, FINAL ORDER AND DECREE GRANTING FINAL APPROVAL OF THE CLASS ACTION SETTLEMENT:
https://www.lymediseaseassociation.org/images/NewDirectory/Government/Vaccines/2003_Vaccine_Judgement_Final_Sttle_Apprvl..pdf


The Principle Investigators of the two previous Lyme vaccines: Allen C. Steere for SmithKline Beecham's LymeRix and Gary Wormser for Connaught's vaccine (which never made it to market) have conceptualized a disease that would enable vaccine development. The one-size-fits-all Lyme treatment guideline (lead author: Gary Wormser) matches the conceptualized disease. This is a flagrant conflict of interest. Post-treatment Lyme disease syndrome is simply a fabricated medical condition disguising treatment failure.

The fraudulent handling of Lyme disease has now been exposed through a recent racketeering lawsuit against the academics that have controlled the Lyme disease narrative for the past thirty years including Wormser and Steere.

You can read the court document here: https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf

A chronic relapsing seronegative disease does not fit the vaccine model so chronic Lyme which is completely devastating to the patient is not recognized and there is no treatment. The disabled Lyme patient is left to fend for himself because treating this class of patient became too expensive as outlined in the racketeering lawsuit. There is a growing community of horribly disabled patients whose disability has gone unrecognized for three decades.

Here’s yet another victim:

Nicole Malachowski: Unfit for Duty from Debilitating Tick-Borne Disease
http://cdmrp.army.mil/cwg/stories/2018/nicole_malachowski_profile


“Her medical retirement, however, was premature. At only 43 years old, she was deemed unfit for duty due to neurological damage from tick-borne illness.”

_____________________________

The latest vaccine from French drug manufacturer Valneva is another OspA vaccine similar to LYMErix so the possibility exists that the class of patient who experienced the debilitating effects of LYMErix could end up with the same results. There was no attempt to uncover why LYMErix disabled the patient as described in the class action. Until we fully understand how Lyme disease disables its victim aren’t we playing Russian roulette with people’s health?

Please distribute this petition update far and wide through social media as the public needs to know the truth and will not obtain this information through fake news outlets.

The following letters to the editors failed to produce full disclosure:

#1 PRECISSION VACCINATIONS

--------- Original Message ----------
From: Carl Tuttle 
To: DonaldHackett@gmail.comDon@PrecisionVax.com
Cc: Karen@PrecisionVax.comDReiter@PrecisionVaccinations.comsitka@outlook.com
Date: May 29, 2018 at 10:03 AM
Subject: Morris County Is New Jersey’s Hot-Spot for Lyme Disease

Morris County Is New Jersey’s Hot-Spot for Lyme Disease
https://www.precisionvaccinations.com/valneva-lyme-disease-vaccine-candidate-vla15-designed-increase-antibodies-prevent-borrelia-migrating

-Valneva Lyme disease vaccine candidate VLA15 is designed to increase antibodies that prevent Borrelia from migrating from ticks to humans

-John Halperin, MD, medical director of Atlantic Neuroscience Institute said, “Ticks have to stay attached for 24 to 48 hours before you’re at serious risk of Lyme disease.”

May 29, 2018

To; PrecisionVaccinations
Attn: Don Ward Hackett, Managing Editor

Dear Mr. Hackett,

There are multiple issues with your recent article regarding New Jersey’s Hot-Spot for Lyme disease.

Valneva’s vaccine is based on the failed OspA vaccine known as LYMErix which was withdrawn from the market by the manufacturer not for poor sales as reported in the media but for the severe and debilitating adverse reactions it produced.

Excerpt from the class action lawsuit: (See attached court document)

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.”

______________________________________

Regarding John Halperin’s statement: “Ticks have to stay attached for 24 to 48 hours before you’re at serious risk of Lyme disease.”

This statement is a continuation of the disinformation campaign which is part of a long running racketeering scheme identified in the Shrader & Associates RICO lawsuit. It should be noted that John Halperin, MD is one of the defendants named in this lawsuit.

You can read the court document here: https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf

Please see the following information regarding transmission times:

1. Clinical evidence for rapid transmission of Lyme disease 
following a tickbite

Eleanor D. Hynote, Phyllis C. Mervine, Raphael B. Stricker
Diagnostic Microbiology and Infectious Disease, online 
before print, November 20, 2011.

http://dx.doi.org/10.1016/j.diagmicrobio.2011.10.003

Abstract

Lyme disease transmission to humans by Ixodes ticks is 
thought to require at least 36–48 h of tick attachment. We 
describe 3 cases in which transmission of Borrelia 
burgdorferi, the spirochetal agent of Lyme disease, appears 
to have occurred in less than 24 h based on the degree of 
tick engorgement, clinical signs of acute infection, and 
immunologic evidence of acute Lyme disease.

Health care providers and individuals exposed to ticks 
should be aware that transmission of Lyme disease may occur 
more rapidly than animal models suggest. A diagnosis of Lyme 
disease should not be ruled out based on a short tick 
attachment time in a subject with clinical evidence of B. 
burgdorferi infection.

2. How Long Does A Tick Need To Be Attached To Transmit Lyme Disease?
https://sites.google.com/site/marylandlyme/ticks/how-long-to-transmit

Michael Cook reports- "The claims that removal of ticks within 24 hours or 48 hours of attachment will effectively prevent LB are not supported by the published data, and the minimum tick attachment time for transmission of LB in humans has never been established."

___________________

From the PrecisionVaccinations.com website:

“If our audiences cannot trust us to get the small things right, how can they trust us on the big things?”

Precision Vaccination’s article requires the truth not more disinformation.

Sincerely,

Carl Tuttle
Lyme Endemic Hudson, NH 03051 (USA)


______________________________


#2 THE BOSTON GLOBE:

--------- Original Message ----------
From: Carl Tuttle 
To: letter@globe.com
Cc: oped@globe.com
Date: June 4, 2018 at 1:31 PM
Subject: How Mass. could disrupt Lyme disease research

How Mass. could disrupt Lyme disease research
https://www.bostonglobe.com/opinion/editorials/2018/06/01/how-mass-could-disrupt-lyme-disease-research/3QuoqWUcwp0SEHegejCxDK/amp.html?event=event25&__twitter_impression=true

“The need for three shots in a single year, feared links to arthritis, and the spread of unfounded anti-vaccine conspiracy theories have most likely left a permanent taint on the idea of a vaccine for the long term, researchers believe.”

June 4, 2018

Letters to the Editor
The Boston Globe
PO Box 55819
Boston, MA 02205

To the Editor,

In reference to the statement above; “unfounded anti-vaccine conspiracy theories” the first Lyme disease vaccine known as LYMErix was withdrawn from the market by the manufacturer not for poor sales as reported in the media but for the severe and debilitating adverse reactions it produced.

Excerpt from the class action lawsuit: (See attached court document)

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.”

Below is the link to the Final Judgement and Approval of the class action against SmithKline Beecham as a settlement was awarded to these individuals.

JUDGEMENT, FINAL ORDER AND DECREE GRANTING FINAL APPROVAL OF THE CLASS ACTION SETTLEMENT:
https://www.lymediseaseassociation.org/images/NewDirectory/Government/Vaccines/2003_Vaccine_Judgement_Final_Sttle_Apprvl..pdf

Whoever wrote the Editorial in the Boston Globe certainly didn’t get their facts straight and a correction should be published.

Carl Tuttle
Lyme Endemic Hudson, NH

Dear Mr. Bernstein,

I received the standard response from my letter to the editor but I think you will agree that my letter identifies serious concerns with the first Lyme vaccine and should be shared with the public. 

You might want to inquire where the source of the information published in the Globe originated from in that editorial.

Sincerely,

-Carl Tuttle
Hudson, NH

___________________________________

#3 CAUDWELL LYMECO CHARITY:

My view on the development of a Lyme disease vaccine
By John Caudwell, Chairman of Caudwell LymeCo Charity
https://caudwelllyme.com/2018/06/05/my-view-on-the-development-of-a-lyme-disease-vaccine/comment-page-1/#comment-730


Carl Tuttle
June 5, 2018 at 12:44 pm

Your comment is awaiting moderation.

The first Lyme disease vaccine known as LYMErix was withdrawn from the market by the manufacturer not for poor sales as reported in the media but for the severe and debilitating adverse reactions it produced. Valneva’s vaccine is based on the same OspA concept that was used in LYMErix.

Excerpt from the class action lawsuit:

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.”

Below is the link to the Final Judgement and Approval of the class action against SmithKline Beecham as a settlement was awarded to these individuals.

JUDGEMENT, FINAL ORDER AND DECREE GRANTING FINAL APPROVAL OF THE CLASS ACTION SETTLEMENT:
https://www.lymediseaseassociation.org/images/NewDirectory/Government/Vaccines/2003_Vaccine_Judgement_Final_Sttle_Apprvl..pdf

Carl Tuttle
Lyme Endemic Hudson, NH USA
________________________________________

#4 ZME SCIENCE

---------- Original Message ----------
From: Carl Tuttle 
To: andrei@zmescience.com
Date: June 6, 2018 at 1:27 PM
Subject: Lyme Disease vaccine set to become available soon, as first trials successfully passed

Lyme Disease vaccine set to become available soon, as first trials successfully passed
BY MIHAI ANDREI
https://www.zmescience.com/medicine/lyme-disease-vaccine-28052018/

Dear Mihai,

Valneva’s vaccine is based on the failed OspA vaccine known as LYMErix which was withdrawn from the market by the manufacturer not for poor sales as reported in the media but for the severe and debilitating adverse reactions it produced.

Excerpt from the class action lawsuit: (See attached court document)

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.”
______________________________________

Below is the link to the Final Judgement and Approval of the class action against SmithKline Beecham as a settlement was awarded to these individuals.

JUDGEMENT, FINAL ORDER AND DECREE GRANTING FINAL APPROVAL OF THE CLASS ACTION SETTLEMENT:
https://www.lymediseaseassociation.org/images/NewDirectory/Government/Vaccines/2003_Vaccine_Judgement_Final_Sttle_Apprvl..pdf

Regarding the mishandling of Lyme disease, a crime has been identified and submitted to the court system here in the United States. There is ample evidence showing that the CDC participated in this scheme through tax payer dollars financing the dishonest science aligning themselves with the defendants.

You can read the court document here: https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf

Will you publish this important information or will you hide it from the reader?

Sincerely,

Carl Tuttle
Lyme Endemic Hudson, NH 03051 (USA)


https://www.change.org/p/1120418/u/22849266?utm_medium=email&utm_source=petition_update&utm_campaign=350132&sfmc_tk=muTSoJdxbwyErD4caEVJdH6bxJ45TCWeETmqEn1wQBdFVqsc%2foYzLP4

Tuesday, June 5, 2018

HPV VACCINE WAKE UP WORLD

Chris KirckofFollow
Here's the TRUTH about gardasil
After Gardasil was licensed and three doses recommended for 11-12 year old girls and teenagers, there were thousands of reports of sudden collapse with unconsciousness within 24 hours, seizures, muscle pain and weakness, disabling fatigue, Guillain Barre Syndrome (GBS), facial paralysis, brain inflammation, rheumatoid arthritis, lupus, blood clots, optic neuritis, multiple sclerosis, strokes, heart and other serious health problems, including death, following receipt of Gardasil vaccine.
The Japanese government stopped giving the Gardasil vaccine in 2013 after health officials recorded nearly 2,000 adverse reactions, according to the Tokyo Times. http://www.tokyotimes.com/side-effects-in-young-girls-take…/
There is the MIT and Stanford educated medical doctor who also has a Master’s Degree in Public Health? The one who is a vaccine developer and has worked for Merck, the manufacturers of the Gardasil vaccine? Dr. Harper has repeatedly spoken out against the HPV vaccine and raised serious concerns about whether it is safe. As reported by CBS News in 2009:http://www.cbsnews.com/news/gardasil-researcher-speaks-out/
The thousands of parents who belong to this non-profit, the parents who followed their doctor’s orders and got the “cervical cancer jab,” as they like to call it in the U.K. http://sanevax.org/uk-association-of-hpv-vaccine-injured-d…/
Dr. Russell Blaylock - (medical doctor and board certified neurosurgeon) explains the complete scientific fraud of the HPV Gardasil cervical cancer vaccine - http://bit.ly/1V9DHa9
Canadian University Professor - condemns the HPV Gardasil cervical cancer vaccine and advises it be pulled from the market immediately because of scientific fraud and the extreme dangers to anyone who may be injected with it - http://bit.ly/1LQ11zc
Denmark Documentary - exposing the deaths and permanent injuries that the Gardasil HPV cervical cancer vaccine is doing to young women there - http://bit.ly/1AJI0dx
Ireland Court Proceedings - as parents of HPV Gardasil cervical cancer vaccine victims sue the government in order to withdraw the approval of the vaccine to be distributed in that country - http://bit.ly/1O7l9UU
Teen boy dies immediately after HPV cervical cancer vaccine - http://bit.ly/29A7jY6
Video of teen girl struck down by Gardasil cervical cancer vaccine poison - http://bit.ly/1CpDd7g
Japanese medical experts issue warning against HPV cervical cancer vaccine - http://bit.ly/29CdEmo
Japanese women sue Japanese government over permanent damage from HPV cervical cancer vaccine - http://bit.ly/2c9SFZ9
Group of parents in Ireland form the support group REGRET after being lied to by the Irish government about the HPV Gardasil cervical cancer vaccine - http://bit.ly/2bV6eQC
The most prestigious medical review board in the world is also questioning the HPV cervical cancer vaccine, which guarantees the science behind this vaccine is fraudulent on all levels - http://bit.ly/1XRFqAf
Lead developer of the HPV vaccine testifies that it's not safe nor effective. NOT SAFE OR EFFECTIVE. http://bit.ly/1SME57B
Dr. Suzanne Humphries on Gardasil
https://www.youtube.com/watch?v=AkyjgY70yPA
Dark side of the HPV vaccine
https://www.youtube.com/watch?v=Lq0wgaZzkcE
Of course if that’s not enough...here’s over 50 studies showing its dangers....
American College of Pediatrics warns of ovarian failure linked to the HPV (Gardasil) cervical cancer vaccine. Side effect or working exactly as designed? You already know the answer. http://bit.ly/2kwyX2A
Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines
https://www.jstage.jst.go.jp/.../55/21/55_55.7217/_article
Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice
https://www.ncbi.nlm.nih.gov/m/pubmed/26425627/
Adverse events following HPV vaccination, Alberta 2006-2014
https://www.ncbi.nlm.nih.gov/m/pubmed/26921782/
Ampiginous choroiditis following quadrivalent human papilloma virus vaccine
http://bjo.bmj.com/content/94/1/137.long
Association of acute cerebellar ataxia and human papilloma virus vaccination: a case report
https://www.ncbi.nlm.nih.gov/m/pubmed/23378179/
Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl
https://www.ncbi.nlm.nih.gov/m/pubmed/21596082/
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil
https://www.ncbi.nlm.nih.gov/m/pubmed/27421722/
Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis
http://ard.bmj.com/content/73/12/e75.long
Brachial plexus neuritis following HPV vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/18602437/
A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
https://www.ncbi.nlm.nih.gov/m/pubmed/25535199/
Cervical cancers after human papillomavirus vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/19155953/
CNS demyelination and quadrivalent HPV vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/18805844/
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase® (2017)
https://link.springer.com/article/10.1007/s40264-016-0456-3
Demyelinating disease and polyvalent human papilloma virus vaccination
http://jnnp.bmj.com/content/82/11/1296.long
Demyelinating disease and vaccination of the human papillomavirus
https://www.ncbi.nlm.nih.gov/m/pubmed/21425100/
Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/18752390/
Erythema multiforme following vaccination for human papillomavirus
https://www.ncbi.nlm.nih.gov/m/pubmed/19887766/
Fibromyalgia-Like Illness in 2 Girls After Human Papillomavirus Vaccination
http://journals.lww.com/.../Fibromyalgia_Like_Illness_in...
HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation
http://insights.ovid.com/crossref...
HPV vaccination syndrome. A questionnaire-based study
https://www.ncbi.nlm.nih.gov/m/pubmed/26354426/
Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.
https://www.ncbi.nlm.nih.gov/m/pubmed/23902317/
Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?
https://www.ncbi.nlm.nih.gov/m/pubmed/23016780/
Human papillomavirus vaccine and systemic lupus erythematosus
https://www.ncbi.nlm.nih.gov/m/pubmed/23624585/
Human papilloma virus vaccine associated uveitis
https://www.ncbi.nlm.nih.gov/m/pubmed/24191906/
Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction - a review of the regulatory evidence from the European Medicines Agency
https://www.ncbi.nlm.nih.gov/m/pubmed/27867145/
Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80
https://www.ncbi.nlm.nih.gov/m/pubmed/22605841/
Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study
https://www.ncbi.nlm.nih.gov/m/pubmed/19050332/
Hypothesis: Human papillomavirus vaccination syndrome--small fiber neuropathy and dysautonomia could be its underlying pathogenesis
https://www.ncbi.nlm.nih.gov/m/pubmed/25990003/
Immune thrombocytopenic purpura following human papillomavirus vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/19464550/
Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis
https://www.ncbi.nlm.nih.gov/m/pubmed/22476507/
Lichenoid Drug Eruption After Human Papillomavirus Vaccination
http://onlinelibrary.wiley.com/doi/10.1111/pde.12516/full
A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis
https://www.ncbi.nlm.nih.gov/m/pubmed/26125978/
Neurologic Complications in HPV Vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/26160812/
Neurologic Complications in HPV Vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/26160812/
On the relationship between human papilloma virus vaccine and autoimmune diseases
https://www.ncbi.nlm.nih.gov/m/pubmed/24468416/
Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus
https://www.ncbi.nlm.nih.gov/m/pubmed/25882168/
Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry
https://www.ncbi.nlm.nih.gov/m/pubmed/27421720/
Pancreatitis following human papillomavirus vaccination
https://www.mja.com.au/.../pancreatitis-following-human...
Panuveitis With Exudative Retinal Detachments After Vaccination Against Human Papilloma Virus
https://www.ncbi.nlm.nih.gov/m/pubmed/26469238/
Peripheral sympathetic nerve dysfunction in adolescent
Japanese girls following immunization with the human papillomavirus vaccine
https://www.ncbi.nlm.nih.gov/m/pubmed/25274229/
Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483914/
Postural tachycardia syndrome following human papillomavirus vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/24102827/
Potential cross-reactivity between HPV16 L1 protein and sudden death-associated antigens
https://www.ncbi.nlm.nih.gov/m/pubmed/21699023/
Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/23035167/
Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld's syndrome).
https://www.ncbi.nlm.nih.gov/m/pubmed/27412294/
Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature
https://www.ncbi.nlm.nih.gov/m/pubmed/27503625/
A 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus
https://www.ncbi.nlm.nih.gov/m/pubmed/20189933/
Small Fiber Neuropathy Following Vaccination
https://www.ncbi.nlm.nih.gov/m/pubmed/27552388/
Syncope and seizures following human papillomavirus vaccination: a retrospective case series
https://www.ncbi.nlm.nih.gov/m/pubmed/21449862/
Telogen effluvium following bivalent human papillomavirus vaccine administration: a report of two cases
https://www.ncbi.nlm.nih.gov/m/pubmed/22584489/
Two Cases of Acute Disseminated Encephalomyelitis Following Vaccination Against Human Papilloma Virus
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140871/
Two unclear cases of death. Can we still recommend HPV vaccination?].
https://www.ncbi.nlm.nih.gov/m/pubmed/18361151/
An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women
https://www.ncbi.nlm.nih.gov/m/pubmed/22580356/
Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial
http://link.springer.com/article/10.1007%2Fs10067-017-3575-z